PULMONX CORPORATION Cost of Revenue
PULMONX CORPORATION (LUNG) reported Cost of Revenue of $5.01 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Expense Statement
us-gaap:CostOfGoodsAndServicesSold · last filed 2026-08-04
- PULMONX CORPORATION cost of goods and services sold for the quarter ending 2026-06-30 was $5.01M, a 24.66% decline year-over-year.
- PULMONX CORPORATION cost of goods and services sold for the quarter ending 2026-03-31 was $4.54M, a 26.69% decline year-over-year.
- PULMONX CORPORATION cost of goods and services sold for the quarter ending 2025-12-31 was $5.06M, a 18.11% decline year-over-year.
- PULMONX CORPORATION cost of goods and services sold for the quarter ending 2025-09-30 was $5.45M, a 1.66% increase year-over-year.
- PULMONX CORPORATION cost of goods and services sold for fiscal 2025 was $23.36M, a 7.21% increase from fiscal 2024.
- PULMONX CORPORATION cost of goods and services sold for fiscal 2024 was $21.79M, a 21.56% increase from fiscal 2023.
- PULMONX CORPORATION cost of goods and services sold for fiscal 2023 was $17.92M, a 29.91% increase from fiscal 2022.
- PULMONX CORPORATION cost of goods and services sold for fiscal 2022 was $13.80M, a 7.91% increase from fiscal 2021.
| Period end | Cost of Goods and Services Sold 3 month | Cost of Goods and Services Sold 6 month | Cost of Goods and Services Sold 9 month | Cost of Goods and Services Sold 12 month |
|---|---|---|---|---|
| 2026-06-30 | $5.01M 10-Q · filed 2026-08-04 | $9.56M 10-Q · filed 2026-08-04 | $14.61M derived: sum of 3 quarters · filed 2026-08-04 | $20.06M derived: sum of 4 quarters · filed 2026-08-04 |
| 2026-03-31 | $4.54M 10-Q · filed 2026-05-04 | $9.60M derived: sum of 2 quarters · filed 2026-05-04 | $15.05M derived: sum of 3 quarters · filed 2026-05-04 | $21.70M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-12-31 | $5.06M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $10.51M derived: sum of 2 quarters · filed 2026-03-10 | $17.16M derived: sum of 3 quarters · filed 2026-08-04 | $23.36M 10-K · filed 2026-03-10 |
| 2025-09-30 | $5.45M 10-Q · filed 2025-11-12 | $12.11M derived: sum of 2 quarters · filed 2026-08-04 | $18.30M 10-Q · filed 2025-11-12 | $24.48M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-06-30 | $6.66M 10-Q · filed 2026-08-04 | $12.85M 10-Q · filed 2026-08-04 | $19.03M derived: sum of 3 quarters · filed 2026-08-04 | $24.39M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-03-31 | $6.20M 10-Q · filed 2026-05-04 | $12.37M derived: sum of 2 quarters · filed 2026-05-04 | $17.73M derived: sum of 3 quarters · filed 2026-05-04 | $23.21M derived: sum of 4 quarters · filed 2026-05-04 |
| 2024-12-31 | $6.17M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $11.54M derived: sum of 2 quarters · filed 2026-03-10 | $17.01M derived: sum of 3 quarters · filed 2026-03-10 | $21.79M 10-K · filed 2026-03-10 |
| 2024-09-30 | $5.36M 10-Q · filed 2025-11-12 | $10.84M derived: sum of 2 quarters · filed 2025-11-12 | $15.61M 10-Q · filed 2025-11-12 | $20.49M derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | $5.48M 10-Q · filed 2025-08-01 | $10.25M 10-Q · filed 2025-08-01 | $15.13M derived: sum of 3 quarters · filed 2025-08-01 | $19.77M derived: sum of 4 quarters · filed 2025-08-01 |
| 2024-03-31 | $4.78M 10-Q · filed 2025-05-02 | $9.65M derived: sum of 2 quarters · filed 2025-05-02 | $14.29M derived: sum of 3 quarters · filed 2025-05-02 | $18.75M derived: sum of 4 quarters · filed 2025-05-02 |
| 2023-12-31 | $4.88M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | $9.52M derived: sum of 2 quarters · filed 2025-02-25 | $13.98M derived: sum of 3 quarters · filed 2025-02-25 | $17.92M 10-K · filed 2025-02-25 |
| 2023-09-30 | $4.64M 10-Q · filed 2024-11-01 | $9.10M derived: sum of 2 quarters · filed 2024-11-01 | $13.04M 10-Q · filed 2024-11-01 | $17.29M derived: sum of 4 quarters · filed 2024-11-01 |
| 2023-06-30 | $4.46M 10-Q · filed 2024-08-02 | $8.41M 10-Q · filed 2024-08-02 | $12.65M derived: sum of 3 quarters · filed 2024-08-02 | $16.00M derived: sum of 4 quarters · filed 2024-08-02 |
| 2023-03-31 | $3.95M 10-Q · filed 2024-05-03 | $8.19M derived: sum of 2 quarters · filed 2024-05-03 | $11.54M derived: sum of 3 quarters · filed 2024-05-03 | $15.07M derived: sum of 4 quarters · filed 2024-05-03 |
| 2022-12-31 | $4.24M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $7.59M derived: sum of 2 quarters · filed 2024-02-27 | $11.12M derived: sum of 3 quarters · filed 2024-02-27 | $13.80M 10-K · filed 2024-02-27 |
| 2022-09-30 | $3.35M 10-Q · filed 2023-11-03 | $6.88M derived: sum of 2 quarters · filed 2023-11-03 | $9.56M 10-Q · filed 2023-11-03 | $13.01M derived: sum of 4 quarters · filed 2023-11-03 |
| 2022-06-30 | $3.53M 10-Q · filed 2023-08-04 | $6.21M 10-Q · filed 2023-08-04 | $9.66M derived: sum of 3 quarters · filed 2023-08-04 | $13.19M derived: sum of 4 quarters · filed 2023-08-04 |
| 2022-03-31 | $2.67M 10-Q · filed 2023-05-08 | $6.13M derived: sum of 2 quarters · filed 2023-05-08 | $9.65M derived: sum of 3 quarters · filed 2023-05-08 | $12.83M derived: sum of 4 quarters · filed 2023-05-08 |
| 2021-12-31 | $3.46M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $6.98M derived: sum of 2 quarters · filed 2023-03-01 | $10.15M derived: sum of 3 quarters · filed 2023-03-01 | $12.79M 10-K · filed 2023-03-01 |
| 2021-09-30 | $3.52M 10-Q · filed 2022-11-08 | $6.70M derived: sum of 2 quarters · filed 2022-11-08 | $9.33M 10-Q · filed 2022-11-08 | $12.08M derived: sum of 4 quarters · filed 2022-11-08 |
| 2021-06-30 | $3.17M 10-Q · filed 2022-08-08 | $5.81M 10-Q · filed 2022-08-08 | $8.56M derived: sum of 3 quarters · filed 2022-08-08 | $11.71M derived: sum of 4 quarters · filed 2022-08-08 |
| 2021-03-31 | $2.63M 10-Q · filed 2022-05-09 | $5.38M derived: sum of 2 quarters · filed 2022-05-09 | $8.54M derived: sum of 3 quarters · filed 2022-05-09 | $11.20M derived: sum of 4 quarters · filed 2022-05-09 |
| 2020-12-31 | $2.75M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $5.90M derived: sum of 2 quarters · filed 2022-03-01 | $8.56M derived: sum of 3 quarters · filed 2022-03-01 | $11.53M 10-K · filed 2022-03-01 |
| 2020-09-30 | $3.15M 10-Q · filed 2021-11-09 | $5.81M derived: sum of 2 quarters · filed 2021-11-09 | $8.78M 10-Q · filed 2021-11-09 | $11.79M derived: sum of 4 quarters · filed 2021-11-09 |
| 2020-06-30 | $2.66M 10-Q · filed 2021-08-10 | $5.63M 10-Q · filed 2021-08-10 | $8.64M derived: sum of 3 quarters · filed 2021-08-10 | $11.34M derived: sum of 4 quarters · filed 2021-08-10 |
| 2020-03-31 | $2.97M 10-Q · filed 2021-05-12 | $5.98M derived: sum of 2 quarters · filed 2021-05-12 | $8.68M derived: sum of 3 quarters · filed 2021-05-12 | |
| 2019-12-31 | $3.01M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-15 | $5.71M derived: sum of 2 quarters · filed 2021-03-15 | $10.18M 10-K · filed 2021-03-15 | |
| 2019-09-30 | $2.70M 10-Q · filed 2020-11-13 | $7.17M 10-Q · filed 2020-11-13 | ||
| 2018-12-31 | $7.72M 10-K · filed 2021-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Spectral AI, Inc. (MDAI) | United States | $0.052B |